Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

GLOBAL: H.I.V./AIDS: Methadone Treatment for Addicts Is Linked to Lower H.I.V. Risk




 

New York Times (10.16.12)

A new study, published October 4 online by the British journal BMJ, has found that treating drug addicts with methadone significantly reduces the risk that they will get HIV or give it to anyone else. The study combined data from studies done in nine countries, and concluded that making methadone available reduced HIV risk by 54 percent. Many countries, including Russia, have large HIV epidemics among addicts; nonetheless, these countries outlaw methadone and buprenorphine treatment for religious, political, or other reasons. Methadone alone does not affect the virus. Scientists believe it works because addicts on treatment become better able to cease selling sex for drugs and stop sharing needles. The addicts are also more likely to stay on antiretroviral drugs, which lower the chance that they will infect others. The authors suggested that opiate-substitution therapy was effective because addicts who are motivated enough to pursue treatment are also smart about protecting themselves in other ways. The study estimated that contaminated needles cause 5 to 10 percent of all the world’s HIV infections. The problem is the most serious in Eastern Europe and Central and Southeast Asia, regions that are located on the fringes of opium-growing areas.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in October 16, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.